pubmed.ncbi.nlm.nih.gov

Brazilian Nutritional Consensus in Hematopoietic Stem Cell Transplantation: children and adolescents - PubMed

  • ️Fri Jan 01 2021

. 2021 Dec 10:19:eAE5254.

doi: 10.31744/einstein_journal/2021AE5254. eCollection 2021.

[Article in English, Portuguese]

Affiliations

Brazilian Nutritional Consensus in Hematopoietic Stem Cell Transplantation: children and adolescents

[Article in English, Portuguese]

Juliana Moura Nabarrete et al. Einstein (Sao Paulo). 2021.

Abstract

The Brazilian Nutritional Consensus in Hematopoietic Stem Cell Transplantation: Children and Adolescents was developed by dietitians, physicians, and pediatric hematologists from 10 Brazilian reference centers in hematopoietic stem cell transplantation. The aim was to emphasize the importance of nutritional status and body composition during treatment, as well as the main characteristics related to patient´s nutritional assessment. This consensus is intended to improve and standardize nutrition therapy during hematopoietic stem cell transplantation. The consensus was approved by the Brazilian Society of Bone Marrow Transplantation.

RESUMO: O Consenso Brasileiro de Nutrição em Transplante de Células-Tronco Hematopoiéticas: crianças e adolescentes foi elaborado com a participação de nutricionistas, médicos nutrólogos e médicos hematologistas pediátricos de 10 centros brasileiros que são referência em transplante de células-tronco hematopoiéticas. O objetivo foi salientar a importância do estado nutricional e da composição corporal durante o tratamento, bem como as principais características relacionadas à avaliação nutricional do paciente. As intenções, ao se estabelecer o consenso, foram aprimorar e padronizar a terapia nutricional durante o transplante de células-tronco hematopoiéticas. O consenso foi aprovado pela Sociedade Brasileira de Transplante de Médula Óssea.

PubMed Disclaimer

Figures

Similar articles

Cited by

References

    1. Forman SJ, Negrin RS, Antin JH, Appelbaum FR. Thomas’ hematopoietic cell transplantation: stem cell transplantation. 5th ed. Vol. 2. New Jersey (USA): Wiley-Blackwell; 2016. p.1416.
    1. Gratwohl A, Pasquini MC, Aljurf M, Atsuta Y, Baldomero H, Foeken L, Gratwohl M, Bouzas LF, Confer D, Frauendorfer K, Gluckman E, Greinix H, Horowitz M, Iida M, Lipton J, Madrigal A, Mohty M, Noel L, Novitzky N, Nunez J, Oudshoorn M, Passweg J, van Rood J, Szer J, Blume K, Appelbaum FR, Kodera Y, Niederwieser D; Worldwide Network for Blood and Marrow Transplantation (WBMT). One million haemopoietic stem-cell transplants: a retrospective observational study. Lancet Haematol. 2015;2(3):e91-100. Erratum in: Lancet Haematol. 2015;2(5):e184. - PubMed
    1. D’Souza A, Lee S, Zhu X, Pasquini M. Current use and trends in hematopoietic cell transplantation in the United States. Biol Blood Marrow Transplant. 2017;23(9):1417-21. - PMC - PubMed
    1. Pasquini M, Wang Z, Horowitz MM, Gale RP. 2013 report from the Center for International Blood and Marrow Transplant Research (CIBMTR): current uses and outcomes of hematopoietic cell transplants for blood and bone marrow disorders. Clin Transpl. 2013:187-97. - PubMed
    1. European Society for Blood and Marrow Transplantation (EBMT). Inborn erros working party ESID EBMT HSCT guidelines 207. Guidelines for haematopoietic stem cell transplantation for primary immunodeficiencies. EBMIT/ESID; 2017 [cited 2019 Dec 10]. Available from: https://www.ebmt.org/sites/default/files/migration_legacy_files/document...

MeSH terms